← back to search

Michael Y. Bonner

Karolinska Institutet · SE
Area of research
Rehabilitation · Immunology
Research interest
Research interests include Magnolia and Illicium research, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Nuclear Receptors and Signaling, and Redox biology and oxidative stress.
h-index
23
citations
1,862
works
53
NIH funding
primary concept
email

Recent publications

Selenium unmasks protective iron armor: A possible defense against cutaneous inflammation and cancer
Biochimica et Biophysica Acta (BBA) - General Subjects 2018cited by 50position: middledoi
Targeting the duality of cancer
npj Precision Oncology 2017cited by 71position: middledoi
Evidence for biochemical barrier restoration: Topical solenopsin analogs improve inflammation and acanthosis in the KC-Tie2 mouse model of psoriasis
Scientific Reports 2017cited by 24position: middledoi
SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis
Oncotarget 2016cited by 108position: middledoi
Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma<i>in vivo</i>
Oncotarget 2016cited by 39position: firstdoi
Use of Polyphenolic Compounds in Dermatologic Oncology
American Journal of Clinical Dermatology 2016cited by 29position: middledoi
Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model
Oncotarget 2016cited by 23position: middledoi
Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
Nature Communications 2015cited by 432position: middledoi
Inactivation of NADPH Oxidases NOX4 and NOX5 Protects Human Primary Fibroblasts from Ionizing Radiation-Induced DNA Damage
Radiation Research 2015cited by 75position: middledoi
Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner
Oncotarget 2015cited by 56position: middledoi
Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer
Oncotarget 2015cited by 52position: middledoi
NADPH oxidase 4 is a critical mediator in Ataxia telangiectasia disease
Proceedings of the National Academy of Sciences 2015cited by 45position: middledoi
Honokiol inhibits epithelial—mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E‐cadherin axis
Molecular Oncology 2014cited by 97position: middledoi
The Antioxidant Paradox: What are Antioxidants and How Should They Be Used in a Therapeutic Context for Cancer
Future Medicinal Chemistry 2014cited by 80position: firstdoi
Honokiol Enhances Paclitaxel Efficacy in Multi-Drug Resistant Human Cancer Model through the Induction of Apoptosis
PLoS ONE 2014cited by 50position: middledoi
Anti-Invasive Adjuvant Therapy with Imipramine Blue Enhances Chemotherapeutic Efficacy Against Glioma
Science Translational Medicine 2012cited by 111position: middledoi
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis
Breast Cancer Research 2012cited by 100position: middledoi
Targeting NADPH oxidases for the treatment of cancer and inflammation
Cellular and Molecular Life Sciences 2012cited by 76position: firstdoi
Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases
Journal of the American Academy of Dermatology 2012cited by 35position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jack L. Arbiser · Emory University19 papers (2012–2018)Dipali Sharma · Johns Hopkins University4 papers (2012–2015)Arumugam Nagalingam · Johns Hopkins Medicine4 papers (2012–2015)Neeraj K. Saxena · Integral University4 papers (2012–2015)Dimiter Avtanski · Johns Hopkins Medicine3 papers (2014–2015)Linda Gilbert · Emory University2 papers (2017–2017)Rohini Choudhuri · National Human Genome Research Institute2 papers (2015–2015)Palak R. Parekh · Center for Cancer Research2 papers (2015–2015)Christophe E. Redon · Center for Cancer Research2 papers (2015–2015) · 2 papers (2015–2015) · 2 papers (2016–2017)Urbain Weyemi · The University of Texas at Austin2 papers (2015–2015)Daisuke Maeda · Center for Cancer Research2 papers (2015–2015)Mahesh P. Gupta · Butler University2 papers (2015–2016)Nicole L. Ward · Case Western Reserve University2 papers (2017–2018)Begoña Díaz · UCLA Medical Center2 papers (2012–2016)Shikha Rao · Texas Tech University2 papers (2017–2018)William M. Bonner · Georgetown University2 papers (2015–2015)Hyung Ju C. Shin · Quest Diagnostics (United States)1 papers (2014–2014)David W. Kamp · Lung Institute1 papers (2016–2016)